CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Six-Drug cocktail tested for Hard-to-Treat brain lymphoma
Disease control OngoingThis study is testing a new combination of six drugs to treat aggressive B-cell lymphoma that has spread to the central nervous system (brain and spinal cord). The goal is to see if this combination is safe and effective at controlling the cancer and preventing it from getting wo…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
Experimental drug trial targets Tough-to-Treat brain cancer
Disease control OngoingThis study is testing whether the drug acalabrutinib can help control recurrent or treatment-resistant lymphoma that has spread to the brain or spinal cord. The trial will enroll about 49 adults who have already tried at least one other treatment for this aggressive cancer. Resea…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New approach aims to shield patients from Chemo's toxic aftermath
Disease control OngoingThis study is testing whether adding a drug called glucarpidase (Voraxaze) to the standard treatment for central nervous system lymphoma helps the body clear the chemotherapy drug methotrexate more quickly. The goal is to see if this faster clearance reduces potential side effect…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radioactive 'Tumor Seeker' drug tested as last hope for tough blood cancers
Disease control OngoingThis study is testing an experimental drug called iopofosine I 131 in people with various advanced B-cell blood cancers that have come back or stopped responding to standard treatments. The drug is designed to deliver radiation directly to cancer cells. The main goal is to see if…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC